Cantel Medical Corp stock page - price, fundamentals, dividends - iOCharts

CMD

80.37
+- (%)
Cantel Medical Corp (NYSE, USD)
Healthcare >
Medical Instruments & Supplies
Market cap
3.40B
Ent value
4.40B
Price/Sales
3.20
Price/Book
4.16
Div yield
0.26%
Div growth
17.32%
Growth years
6
FCF payout
5.16%
Trailing P/E
72.77
Forward P/E
25.12
PEG
26.46
EPS growth
5.40%
1 year return
85.91%
3 year return
-9.68%
5 year return
3.88%
10 year return
22.86%
Last updated: 2021-09-17

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open80.37
Daily high80.37
Daily low80.37
Daily Volume0K
All-time high129.78
1y analyst estimate62.00
Beta1.55
EPS (TTM)1.11
Dividend per share0.21
Ex-div date16 Jan 2020
Next earnings date-

Downside potential

Loading...
Downside potential data
CMDS&P500
Current price drop from All-time high-38.07%-0.42%
Highest price drop-83.23%-56.47%
Date of highest drop23 Mar 20209 Mar 2009
Avg drop from high-28.70%-11.48%
Avg time to new high24 days12 days
Max time to new high1710 days1805 days

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share0.21
Dividend yield0.26%
Payout frequencySemi-annual
Maximum yield0.97%
Average yield0.26%
Minimum yield0.13%
Discount to avg yield-0.29%
Upside potential-0.29%
Yield as % of max yield27.07%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield0.26%
Current yield distribution37.86%
Yield at 100% (Min)0.13%
Yield at 90%0.17%
Yield at 80%0.18%
Yield at 50% (Median)0.23%
Yield at 20%0.30%
Yield at 10%0.42%
Yield at 0% (Max)0.97%

Dividend per share

Loading...
Dividend per share data
Years of growth6 years
CCC statusDividend Challenger
Dividend per share0.21
Payout frequencySemi-annual
Ex-div date16 Jan 2020
EPS (TTM)1.11
EPS (1y forward)3.20
EPS growth (5y)5.40%
EPS growth (5y forward)2.75%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
CMDS&P500
DGR MR5.00%7.68%
DGR TTM10.81%-2.66%
DGR 3 years18.56%5.82%
DGR 5 years17.32%6.23%
DGR 10 years-9.64%
DGR 15 years-6.71%
Time since last change announced640 days
EPS growth (5y)5.40%
EPS growth (5y forward)2.75%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM19.13%5.16%
Average--
Forward6.56%-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E72.77
Price to OCF16.75
Price to FCF19.62
Price to EBITDA25.98
EV to EBITDA33.59

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales3.20
Price to Book4.16
EV to Sales4.14

FINANCIALS

Per share

Loading...
Per share data
Current share count42.31M
EPS (TTM)1.11
FCF per share (TTM)4.10

Income statement

Loading...
Income statement data
Revenue (TTM)1.06B
Gross profit (TTM)488.70M
Operating income (TTM)108.27M
Net income (TTM)46.74M
EPS (TTM)1.11
EPS (1y forward)3.20

Margins

Loading...
Margins data
Gross margin (TTM)46.04%
Operating margin (TTM)10.20%
Profit margin (TTM)4.40%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash218.53M
Net receivables164.93M
Total current assets626.00M
Goodwill666.22M
Intangible assets454.77M
Property, plant and equipment227.63M
Total assets2.03B
Accounts payable58.95M
Short/Current long term debt40.08M
Total current liabilities242.95M
Total liabilities1.21B
Shareholder's equity817.19M
Net tangible assets-303.80M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)203.08M
Capital expenditures (TTM)29.71M
Free cash flow (TTM)173.37M
Dividends paid (TTM)8.94M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity5.93%
Return on Assets2.28%
Return on Invested Capital2.71%
Cash Return on Invested Capital10.04%
COMPANY DETAILS
CMD (Cantel Medical Corp) company logo
Marketcap
3.40B
Marketcap category
Mid-cap
Description
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.
Employees
3669
Investor relations
SEC filings
CEO
George Fotiades
Country
USA
City
Little Falls
Stock type
Common stock
CCC status
Dividend Challenger
Dividend Frequency
Semi-annual
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
June 7, 2021
STERIS' (STE) acquisition of Cantel Medical will complement and broaden the former's product and service offerings, global reach and customers.
May 26, 2021
S&P SmallCap 600 constituent Crocs Inc. (NASD:CROX) will replace Cantel Medical Corp. (NYSE:CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. (NASD: ORGO) will replace Crocs in the S&P Small...
May 6, 2021
Mar Cor launches the EON Portable RO Dialysis Water System. It produces high-quality medical water for acute and home hemodialysis use.
April 28, 2021
When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right...
April 26, 2021
Cantel (CMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
April 23, 2021
The Dow Jones industrials posted solid gains in today's market as the major indexes traded near session highs. Stocks recovered from the prior day's sell-off.
April 20, 2021
Walgreens' (WBA) recent deal with Abbott is part of its ongoing efforts to offer greater testing access, helping reduce the spread of COVID-19 and improve the health of communities.
April 19, 2021
Investors are optimistic about STERIS (STE) backed by elevated consumer demand and strong segmental growth in third-quarter fiscal 2021.
April 16, 2021
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:
April 15, 2021
Amedisys' (AMED) new agreement to acquire Randolph Country regulatory assets will broaden the company's footprint in the Home Health care market.
Next page